Gamijeonssibaekchulsan regulates mast cell-mediated anaphylactic reaction

Acta Biochimica Polonica

Volumn 54, Issue 2, 2007, Pages 349-355

  Moon, Phil Dong ^a,b   Shin, Hye Young ^c   Na, Ho Jeong ^c   Jeong, Hyun Ja ^a,b   Kim, Su Jin ^a,b   Um, Jae Young ^a   Park, Rae Kil ^b   Kim, Hyung Min ^a   Hong, Seung Heon ^b  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Woosuk University   (South Korea)

Author keywords

Gamijeonssibaekchulsan; Histamine; Molt 4 cells; Passive cutaneous anaphylaxis

Indexed keywords

MURINAE; MUS; RATTUS;

EID: 34447297015     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2007_3256     Document Type: Article

References (38)

1. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383: 787-793.
2. Alber G, Miller L, Jelsema C, Varin-Blank N, Metzger H (1991) Structure-function relationships in the mast cell high affinity receptor for IgE. Role of the cytoplasmic domains and of the beta subunit. J Biol Chem 266: 22613-22620.
3. Alfonso A, Cabado AG, Vieytes MR, Botana LM (2000) Functional compartments in rat mast cells for cAMP and calcium on histamine release. Cell Signal 12: 343-350.
4. Bazin H, Barta O, Barta VD (1990) Hypersensibility de type ?. In Immunologie animale (Pastoret P, Govaerts A, Bazin H, eds) pp 313. Flammarion, Paris.
5. Boothby M, Mora AL, Aronica MA, Youn J, Sheller JR, Goenka S, Stephenson L (2001) IL-4 signaling, gene transcription regulation, and the control of effector T cells. Immunol Res 23: 179-191.
6. Carter LL, Dutton RW (1996) Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 8: 336-342.
7. Chadi A, Fraundorfer PF, Beaven MA (2000) Compound 48/80 activates mast cell phospholipase D via heterotrimeric GTP-binding proteins. J Pharmacol Exp Ther 292: 122-130.
8. Daeron M (1997) Fc receptor biology. Annu Rev Immunol 15: 203-234.
9. Dalgleish AG (2000) Cancer vaccines. Br J Cancer 82: 1619-1624.
10. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M (2005a) Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23: 749-786.
11. Galli SJ, Nakae S, Tsai M (2005b) Mast cells in the development of adaptive immune responses. Nat Immunol 6: 135-142.
12. Jeong HJ, Kim BS, Kim KS, Kim HM (2002) Regulatory effect of cytokine production in asthma patients by SOOJI CHIM (Koryo Hand Acupuncture Therapy). Immunopharmacol Immunotoxicol 24: 265-274.
13. Jeong HJ, Lee SA, Moon PD, Na HJ, Park RK, Um JY, Kim HM, Hong SH (2006) Alginic acid has anti-anaphylactic effects and inhibits inflammatory cytokine expression via suppression of nuclear factor-kappaB activation. Clin Exp Allergy 36: 785-794.
14. Jippo-Kanemoto T, Kasugai T, Yamatodani A, Ushio H, Mochizuki T, Tohya K, Kimura M, Nishimura M, Kitamura Y (1993) Supernormal histamine release and normal cytotoxic activity of beige (Chediak-Higashi syndrome) rat mast cells with giant granules. Int Arch Allergy Immunol 100: 99-106.
15. Katayama S, Shionoya H, Ohtake S (1978) A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous allergy in guinea pigs and rats. Microbiol Immunol 22: 89-101.
16. Kim HM, Yang DJ (1999) Effect of Kumhwang-san on anaphylactic reaction in a murine model. Immunopharmacol Immunotoxicol 21: 163-174.
17. Kim HM, Shin HY, Jeong HJ, An HJ, Kim NS, Chae HJ, Kim HR, Song HJ, Kim KY, Baek SH, Cho KH, Moon BS, Lee YM (2000) Reduced IL-2 but elevated IL-4, IL-6 and IgE serum levels in patients with cerebral infarction during the acute stage. J Mol Neurosci 14: 191-196.
18. Metzger H, Alcaraz G, Gogman R, Kinet JP, Pribluda V, Quarto R (1986) The receptor with high affinity for immunoglobulin E. Annu Rev Immunol 4: 419-470.
19. Miescher SM, Vogel M (2002) Molecular aspects of allergy. Mol Aspects Med 23: 413-462.
20. Moon PD, Choi IY, Na HJ, Jeong HJ, Kim CH, Kim HR, Kim YK, Park SK, Hong SH, Kim HM (2004) Rubus croceacanthus Leveille inhibits mast cell-mediated anaphylactic-like reaction and tumor necrosis factor-α secretion. Biol Pharm Bull 27: 1359-1363.
21. Moon PD, Na HJ, Jeong HJ, Hong SH, Kim SJ, Chae HJ, Kim HR, Choi JO, Lee SH, Shin JY, Kim HM (2005) Inhibitory effect of Gamibojungikgitang extract on mast cell-mediated allergic reaction in murine model. J Pharm Pharm Sci 8: 94-101.
22. Moon PD, Lee BH, Jeong HJ, An HJ, Park SJ, Kim HR, Ko SG, Um JY, Hong SH, Kim HM (2007a) Use of scopoletin to inhibit the production of inflammatory cytokines through inhibition of the IκB/NF-κB signal cascade in the human mast cell line HMC-1. Eur J Pharmacol 555: 218-225.
23. Moon PD, Jeong HJ, Kim SJ, An HJ, Lee HJ, Yang WM, Park SK, Hong SH, Kim HM, Um JY (2007b) Use of electroacupuncture at ST36 to inhibit anaphylactic and inflammatory reaction in mice. Neuroimmunomodulation (in press).
24. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
25. Mosmann TR, Cherwinski H, Bond MW, Gieldin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357.
26. Mousli MC, Bronner C, Bockaert J, Rouot B, Landry Y (1990a) Interaction of substance P, compound 48/80 and mastoparan with α-subunit C-terminal of G protein. Immunol Lett 25: 355-358.
27. Mousli MC, Bronner C, Landry Y, Bockaert J, Rouot B (1990b) Direct activation of GTP-binding regulatory proteins (G proteins) by substance P and compound 48/80. FEBS Lett 25: 260-262.
28. Na HJ, Moon PD, Hong SH, Shin JY, Kim HM (2004) Inhibitory effect of yunbutang on mast cell-dependent allergic reactions. Immunopharmacol Immunotoxicol 26: 233-242.
29. Paul WE, Seder RA (1994) Lymphocyte responses and cytokines. Cell 76: 241-251.
30. Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809.
31. Shore PA, Burkhalter A, Cohn VH (1959) A method for fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 127: 182-186.
32. Singh VK, Mehrotra S, Agarwal SS (1999) The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol Res 20: 147-161.
33. Spellberg B, Edwards JE Jr (2001) Type 1/type 2 immunity in infectious diseases. Clin Infect Dis 32: 76-102.
34. Stephens R, Eisenbarth SC, Chaplin DD (2002) T helper type 1 cells in asthma: friend or foe? Curr Opin Allergy Clin Immunol 2: 31-37.
35. Tasaka K, Mio M, Okamoto M (1986) Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy 56: 464-469.
36. Verdier F, Chazal I, Descotes J (1994) Anaphylaxis models in the guinea-pig. Toxicology 93: 55-61.
37. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin: demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 139: 2605-2614.
38. Yurt RW, Leid RW, Austen KF (1977) Native heparin from rat peritoneal mast cells. J Biol Chem 252: 518-521.